• WisBusiness

Thursday, June 12, 2008

 7:31 PM 

The Wisconsin "BioTheater" Returns for 2nd Year

The Wisconsin "BioTheater" returns this year with a line up of 16 presenters representing some of Wisconsin's top biotech companies and organizations.

Company presentations will take place over the course of two days, with a pavilion appearance by Governor Doyle and special guest Steven Burrill.

Presentations are scheduled as followed. Check back to the Wisconsin BIOBlog as we cover these and other presentations throughout the conference.

Wednesday, June 18
10:30 a.m.
EraGen Biosciences, Inc., Miguel Blanc, VP of
Corporate Development, EraGen Biosciences:
Driving a New Era of Molecular Diagnostics
11:00 a.m. Planet LLC, Thomas Crabb, President and
Dr. Robert Morrow, Senior Scientist
Optimized Environments for Biomanufacturing
11:30 a.m. Wisconsin Alumni Research Foundation, Laura
Heisler, Program Developer of Morgridge Institute
for Research, The Wisconsin Institutes for Discovery:
Creating an Environment to Bridge Gaps Between
2:00 p.m. InViragen, Inc., Dr. Dan T. Stinchcomb, CEO
Worldwide Vaccines for Emerging Infectious Diseases
2:30 p.m. FluGen, Inc., Paul V. Radspinner, President & CEO
FluGen: Transforming Influenza Prevention &
3:00 p.m. Marshfield Clinic Applied Sciences, Catherine A.
McCarty, Ph.D., MPH, Senior Epidemiologist and
Interim Director, Marshfield Clinic's Personalized
Medicine Research Project
3:30 p.m. CDI Bioscience, Thomas Primiano, Ph.D., President
& CEO, PACE Cell Technology
4:00 p.m. Governor Jim Doyle with special guest Steven Burrill

Thursday, June 19
10:30 a.m. SciLog, Inc., Juliette Schick, Ph.D., President
Single-Use Sensors in Bioprocessing
11:00 a.m. Invivosciences LLC, Ms. Ayla Annac, President/CEO,
Co-Founder, Engineered Tissue Based High-Content
Analysis System: Bridging the Gap in Discovery
Between Animal Studies & Cell Based Assays
11:30 a.m. Covance Inc., Philip Teitelbaum, Ph.D., Director of
Program Management Services, Considerations
in the Preclinical Safety Evaluation of New Drug
2:00 p.m. Neoclone, Deven McGlenn, CEO
Monoclonal Antibodies and Biomarkers
2:30 p.m. Cell Line Genetics, LLC, Rob Herrera, Chief
Business Officer, Stem Cell Research Quality
Assurance: Essential, not Optional
3:00 p.m. High Throughput Genomics, Inc. (HTG, Inc.),
Jonathan M. Sheridan, VP of Commercial Operations,
HTG Inc. Tools for Genomics-Driven Discovery
3:30 p.m. Centrose LLC, Dr. James Prudent, CEO
Sweeter Pathways to New Medicines
4:00 p.m. WiCell Research Institute, Erik Forsberg, Executive
Director, Wisconsin's Role in the Future of Cell-
Based Medicine




wisbusiness.com Social News

Follow Us

Site Sponsors


· 04/01/2006 - 05/01/2006
· 05/01/2007 - 06/01/2007
· 06/01/2008 - 07/01/2008
· 05/01/2009 - 06/01/2009
· 10/01/2009 - 11/01/2009
· 01/01/2010 - 02/01/2010
· 02/01/2010 - 03/01/2010
· 03/01/2010 - 04/01/2010
· 04/01/2010 - 05/01/2010
· 05/01/2010 - 06/01/2010
· 06/01/2011 - 07/01/2011
· 07/01/2011 - 08/01/2011
· 06/01/2012 - 07/01/2012
Copyright ©2012 WisBusiness.com All rights reserved. | WisOpinion.com | WisPolitics.com  |  Website development by wisnet.com LLC  | Website design by Makin’ Hey Communications